Rachel Klemovitch, Assistant Editor04.04.24
Silk Road Medical added to its TCAR portfolio with the release of its ENROUTE Transcarotid Neuroprotection System PLUS (NPS PLUS). This device builds on the prior ENROUTE Transcarotid Neuroprotection System to deliver smoother arterial sheath insertion, greater flow precision, and a simplified prep experience for surgical teams, while maintaining unparalleled neuroprotection during the TCAR procedure.
The TCAR procedure offers a more patient-friendly, less invasive approach to treating carotid artery disease, providing neuroprotection akin to open surgical techniques. TCAR delivers less than 1% periprocedural stroke rates and a better patient recovery experience than open surgery.
During TCAR, the surgical team inserts a tube-like sheath into the carotid artery and connects it to the ENROUTE Neuroprotection System, which temporarily reverses blood flow. The system filters potentially dangerous debris from the blood to reduce intraprocedural stroke risk while the team uses a TCAR-specific balloon and stent to open the artery and contain the carotid artery disease.
“With the launch of the NPS PLUS, we're thrilled to empower our TCAR-trained physicians with a solution that addresses their insights and feedback to further strengthen and streamline the TCAR procedure,” said Silk Road Medical CEO, Chas McKhann. “Our focus on new product innovation reflects our ongoing commitment to leadership in the treatment of carotid disease.”
“Silk Road Medical's responsiveness to our feedback has provided us with better procedure predictability and a more streamlined workflow for our entire surgical team," commented Brian Peterson, MD, FACS, FSVS of St. Luke’s Heart and Vascular Institute. "With over 500 TCAR procedures performed by our team, we view TCAR as a first-line treatment option for carotid disease and we’re excited about what these improvements mean for patient care.”
The TCAR procedure offers a more patient-friendly, less invasive approach to treating carotid artery disease, providing neuroprotection akin to open surgical techniques. TCAR delivers less than 1% periprocedural stroke rates and a better patient recovery experience than open surgery.
During TCAR, the surgical team inserts a tube-like sheath into the carotid artery and connects it to the ENROUTE Neuroprotection System, which temporarily reverses blood flow. The system filters potentially dangerous debris from the blood to reduce intraprocedural stroke risk while the team uses a TCAR-specific balloon and stent to open the artery and contain the carotid artery disease.
“With the launch of the NPS PLUS, we're thrilled to empower our TCAR-trained physicians with a solution that addresses their insights and feedback to further strengthen and streamline the TCAR procedure,” said Silk Road Medical CEO, Chas McKhann. “Our focus on new product innovation reflects our ongoing commitment to leadership in the treatment of carotid disease.”
“Silk Road Medical's responsiveness to our feedback has provided us with better procedure predictability and a more streamlined workflow for our entire surgical team," commented Brian Peterson, MD, FACS, FSVS of St. Luke’s Heart and Vascular Institute. "With over 500 TCAR procedures performed by our team, we view TCAR as a first-line treatment option for carotid disease and we’re excited about what these improvements mean for patient care.”